TriMas Co. (NASDAQ:TRS – Free Report) – Equities researchers at Zacks Research lifted their Q4 2024 EPS estimates for TriMas in a note issued to investors on Monday, January 27th. Zacks Research analyst M. Das now expects that the industrial products company will post earnings per share of $0.48 for the quarter, up from their previous forecast of $0.47. The consensus estimate for TriMas’ current full-year earnings is $1.69 per share. Zacks Research also issued estimates for TriMas’ Q3 2025 earnings at $0.59 EPS, Q4 2026 earnings at $0.50 EPS and FY2026 earnings at $2.10 EPS.
Several other equities research analysts have also recently commented on TRS. BWS Financial reaffirmed a “buy” rating and issued a $40.00 price target on shares of TriMas in a report on Thursday, January 23rd. StockNews.com upgraded TriMas from a “sell” rating to a “hold” rating in a report on Wednesday, November 13th.
TriMas Trading Down 1.8 %
TRS opened at $24.67 on Wednesday. The firm has a market capitalization of $1.00 billion, a price-to-earnings ratio of 38.55 and a beta of 0.67. The company’s 50 day simple moving average is $25.03 and its two-hundred day simple moving average is $25.44. TriMas has a 1-year low of $22.24 and a 1-year high of $28.51. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44.
TriMas (NASDAQ:TRS – Get Free Report) last issued its earnings results on Monday, November 4th. The industrial products company reported $0.43 EPS for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.14). The business had revenue of $229.36 million during the quarter, compared to analyst estimates of $239.33 million. TriMas had a net margin of 2.93% and a return on equity of 9.21%. TriMas’s quarterly revenue was down 2.5% on a year-over-year basis. During the same quarter last year, the company earned $0.57 earnings per share.
Institutional Investors Weigh In On TriMas
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. JPMorgan Chase & Co. grew its holdings in shares of TriMas by 3.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 38,461 shares of the industrial products company’s stock worth $982,000 after purchasing an additional 1,227 shares during the period. Barclays PLC boosted its stake in TriMas by 341.3% during the third quarter. Barclays PLC now owns 68,792 shares of the industrial products company’s stock worth $1,755,000 after buying an additional 53,203 shares during the period. XTX Topco Ltd acquired a new stake in shares of TriMas during the third quarter valued at about $371,000. Jane Street Group LLC raised its stake in shares of TriMas by 74.4% in the 3rd quarter. Jane Street Group LLC now owns 82,621 shares of the industrial products company’s stock valued at $2,109,000 after acquiring an additional 35,258 shares during the period. Finally, Wellington Management Group LLP lifted its holdings in shares of TriMas by 10.7% in the 3rd quarter. Wellington Management Group LLP now owns 2,619,359 shares of the industrial products company’s stock worth $66,872,000 after acquiring an additional 252,537 shares during the last quarter. Institutional investors and hedge funds own 99.42% of the company’s stock.
TriMas Company Profile
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
See Also
- Five stocks we like better than TriMas
- How to Use the MarketBeat Stock Screener
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Why Invest in 5G? How to Invest in 5G Stocks
- What Does the Future Hold for Eli Lilly?
- The Basics of Support and Resistance
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.